Pharmaron Beijing Co. Ltd (PHBBF) reported earnings for its first quarter that Increased, from the same period last year
The company's bottom line came in at RMB335.36 million, or RMB0.1850 per share. This compares with RMB305.58 million, or RMB0.1733 per share, last year.
The company's revenue for the period rose 15.5% to RMB3.578 billion from RMB3.098 billion last year.
Pharmaron Beijing Co. Ltd earnings at a glance (GAAP) :
-Earnings: RMB335.36 Mln. vs. RMB305.58 Mln. last year.-EPS: RMB0.1850 vs. RMB0.1733 last year.-Revenue: RMB3.578 Bln vs. RMB3.098 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.